HK:9966 Stock Latest News
Company AnnouncementsAlphamab Oncology Clarifies Ownership in Pathos AI Investment3d ago9966
Company AnnouncementsAlphamab Oncology Starts Phase III Trial of Novel Cervical Cancer Therapy JSKN0334d ago9966
Company AnnouncementsAlphamab Oncology Grants 300,000 Restricted Award Shares Under Employee Scheme5d ago9966
Company AnnouncementsAlphamab’s JSKN003 Shows Strong Efficacy in Gastric and Ovarian Cancer Trials6d ago9966
Company AnnouncementsAlphamab’s Anbenitamab Delivers Strong Phase III Results in HER2-Positive Breast Cancer6d ago9966
Company AnnouncementsAlphamab Oncology’s JSKN033 Shows Strong Cervical Cancer Data, Backing Phase III Push6d ago9966Company AnnouncementsAlphamab Oncology Invests US$62.5 Million in Pathos AI via Warrant Exercise1w ago9966
Company AnnouncementsAlphamab Oncology Launches HK$80 Million On-Market Share Buyback Plan2M ago9966
Company AnnouncementsAlphamab Oncology Swings to Loss as R&D Surge Drives Aggressive Cancer Pipeline Expansion2M ago9966- Company AnnouncementsAlphamab Oncology’s HER2 Drug Anbenitamab Wins Priority NMPA Review for First-Line Breast Cancer2M ago9966
- Company AnnouncementsAlphamab Oncology Sets Board Meeting to Approve 2026 Interim Results2M ago9966
Company AnnouncementsAlphamab’s Anbenitamab Breast Cancer NDA Gains Priority Review in China2M ago9966
Company AnnouncementsAlphamab licenses key cancer drug JSKN016 to Pathos AI in US$2.1 billion-plus deal2M ago9966
Company AnnouncementsAlphamab’s Anbenitamab Wins Breakthrough Status Again in HER2+ Breast Cancer3M ago9966
Company AnnouncementsAlphamab Oncology Gains Strong Shareholder Backing for Capital Mandates and Board Re-elections4M ago9966
Company AnnouncementsAlphamab’s Anbenitamab Scores Phase III Win in HER2+ Breast Cancer4M ago9966
Company AnnouncementsAlphamab Executives Lift Stakes as HER2 Oncology Pipeline Advances4M ago9966
Company AnnouncementsAlphamab’s Anbenitamab Delivers Superior Phase III Results in HER2-Positive Breast Cancer5M ago9966Company AnnouncementsAlphamab Wins China Approval for First HER2 Bispecific Antibody in Gastric Cancer5M ago9966
Company AnnouncementsAlphamab Oncology Sets AGM to Seek Share Buyback and Issuance Mandates5M ago9966
